Executive Director, Payer Strategy & Engagement, Tumor HI Program

The Company is seeking an Executive Director of Payer Strategy and Engagement to lead market access strategies for a rare-disease program. Responsibilities include developing disease and product value propositions, pricing and reimbursement strategies, economic models, payer materials, and provider and patient support tools. The role will assess policy and legislative developments, access risks, competitive trends, and opportunities across US and international markets, while supporting coding initiatives and evidence generation. The Executive Director will lead payer engagement, address coverage and authorization barriers, manage external agency relationships, and provide market access expertise across the organization. Candidates must have rare or orphan drug experience and product launch experience, with at least 10 years in biotechnology or pharmaceuticals and five years in US market access and reimbursement. A bachelor’s degree is required; an advanced degree in a relevant medical, business, or health-related field is preferred. Strong analytical skills, knowledge of pricing, reimbursement, healthcare policy, and regulatory requirements, and the ability to lead projects and build effective stakeholder relationships are essential. Excellent communication and presentation skills, sound business judgment, a compliance-focused approach, and advanced Microsoft Office skills are also required.